Nathan Smith
Chief Executive / NeuroScientific Biopharmaceuticals
| Rank | Company | # | |
|---|---|---|---|
| 158th | - | NeuroScientific Biopharmaceuticals | $0 |
| Rank | Company | 1 Yr | 5 Yr |
|---|---|---|---|
| 399th | Whitehaven Coal | 59.62% | 47.72% |
| 400th | Venus Metals Corporation | 59.26% | 13.06% |
| 401st | NeuroScientific Biopharmaceuticals | 58.67% | -22.08% |
| 402nd | IperionX | 57.99% | 39.09% |
| 403rd | Ark Mines | 57.52% | 56.1% |
|
NEWS: Tagged in NeuroScientific hails 80% clinical response in Crohn’s stem cell program | 26 May 2026 |
|
NEWS: Tagged in NeuroScientific readies stem cell supply boost for bowel disease trials | 17 Mar 2026 |
|
NEWS: Tagged in NeuroScientific Biopharmaceuticals soars on stem cell tech results | 13 Jan 2026 |
|
NEWS: Tagged in NeuroScientific widens chronic bowel disease stem cell therapy program | 11 Nov 2025 |
|
NEWS: Tagged in NeuroScientific locks in deal to scale-up stem cell production | 31 Jul 2025 |
|
NEWS: Tagged in Board moves July 29, 2025 | 29 Jul 2025 |
|
NEW ROLE: Chief Executive, NeuroScientific Biopharmaceuticals | 29 Jul 2025 |
Access to our data for Nathan Smith is only available to paid subscribers with Data & Insights access.
Data & Insights is Western Australia's most accurate and comprehensive business listings and searchable database.
Nathan Smith is linked to 1 organisation which is included in 1 list - Public Companies - Industrial WA.
To see the data you will need to Subscribe.